Skip to main content

Best Practices

Automating Monitoring Can Improve Patient Care, Advance the Role of Clinical Pharmacists
Best Practices
June 2024 Vol 17, No 3
The current literature describes various methods by which pharmacists can achieve pharmacovigilance in oncology clinical practice. Finn and colleagues completed a retrospective chart review that showed a 6-fold increase in pharmacovigilance observations via pharmacist interventions with the implementation of EPIC Beacon in the electronic health record (EHR). Read More ›
The Role of Oncology Pharmacists in Reducing Costs and Streamlining Processes in Cancer Centers
Best Practices, ACCC Highlights
July 2023 Vol 16, No 4 – Online Only
At the Association of Community Cancer Centers 49th Annual Meeting & Cancer Business Summit, Andre Harvin, PharmD, MS, MBA, Executive Director of Pharmacy, Oncology Services, Cone Health Cancer Center, Greensboro, NC, presented a keynote lecture titled, “Robots, Biologics, and Advocates: Lessons from the Pharmacy.” Read More ›

An interview with Andre Harvin, PharmD, MS, MBA

Alum Irrigation, a Standard of Care, Is Once Again Readily Available for the Treatment of Hemorrhagic Cystitis
By Dawn Holcombe, MBA, FACMPE, ACHE
Best Practices
TOP - May 2022 Vol 15, No 3
On June 1, 2008, the United States Pharmacopeia (USP) General Chapter 797 Pharmaceutical Compounding – Sterile Compounding (USP ) was made official. Read More ›
Dawn Holcombe, MBA, FACMPE, ACHE
Addressing and Overcoming Challenges in the Use of Biosimilars
By Dawn Holcombe, MBA, FACMPE, ACHE
Best Practices, Biosimilars
TOP - October 2021 Vol 14, No 6 | Biosimilars
Although the role of biosimilars in the treatment of patients with cancer has been under review by payers and providers for several years, there remains conflicting application regarding policy and strategy. Read More ›
Dawn Holcombe, MBA, FACMPE, ACHE
Multidisciplinary Team Approach Leads to Rapid Biosimilar Adoption in Community Oncology Practice
By Charlie Dawson
Best Practices, Biosimilars
TOP - October 2021 Vol 14, No 6 | Biosimilars
Biosimilars have the potential to create a more sustainable healthcare environment by offering substantial cost-savings and expanding patient access to life-saving therapies. Read More ›
Charlie Dawson
Study Shows Increase in Biosimilar Use Among Oncology Providers
By Anne Rowe
Best Practices, Biosimilars
TOP - October 2021 Vol 14, No 6 | Biosimilars
The advent of biologic drugs has had a significant impact on the management of patients with cancer. However, the high costs associated with these agents can hinder treatment access for many patients and place a significant burden on healthcare systems. Read More ›
Anne Rowe
Complying with Pharmacy Standards: USP 797/USP 800
Complying with Pharmacy Standards: USP 797/USP 800
By Gail Thompson
Best Practices
Web Exclusives

Three cancer centers share their experiences related to the struggle of understanding wide variations in the application of sterile compounding and safe handling of oncology hazardous drugs, and the costs and operating burdens of compliance with and adherence to current pharmacy standards.

Read More ›
Gail Thompson
Using Cancer Drugs Wisely to Control Costs: Targeted Therapies May Hold the Key
Using Cancer Drugs Wisely to Control Costs: Targeted Therapies May Hold the Key
By Gail Thompson
Best Practices
TOP - August 2018, Vol 11, No 2

“It is time for us to bury the concept of maximum-tolerated dose in the world of targeted therapy,” according to Allen S. Lichter, MD, FASCO.

Read More ›
Gail Thompson
NCCN Campaign May Prevent Fatal Medication Errors by Targeting Vincristine Preparation
By Caroline Helwick
Best Practices
TOP - February 2017, Vol 10, No 1
A persistent medi­­cation safety issue is getting the attention it has long deserved. In an effort to save lives related to the accidental intrathecal dosing of vincristine, the National Comprehensive Cancer Network (NCCN) has launched a program called “Just Bag It: The NCCN Campaign for Safe Handling of Vincristine." Read More ›
Caroline Helwick
New Survey Reveals How Pharmacies Manage Verification Processes
By Audrey Andrews
Best Practices
TOP - November 2016, Vol 9, No 4

Hollywood, FL—Results from a survey of oncology pharmacists from across the country indicate that the verification process for chemotherapy orders is not uniformly electronic. In fact, >25% of responders are still using paper orders, said Carly Duncan, PharmD candidate, of the Cleveland Clinic Florida, Weston. She presented findings from her and her colleagues’ survey at the 2016 annual conference of the National Comprehensive Cancer Network.

Read More ›
Audrey Andrews

Page 1 of 3